Lehrstuhl für Innere Medizin III

Systemic lupus erythematosus damage risk index (SLE-DRI): a simple machine learning-based tool for identifying patients at risk for early organ damage (2025) Garantziotis P, Nikolopoulos D, Katechis S, Temiz SA, Nöthling DM, Adamichou C, Bergmann C, et al. Journal article CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis (2025) Müller F, Atreya R, Völkl S, Aigner M, Kretschmann S, Kharboutli S, Leppkes M, et al. Journal article Chimeric antigen receptor T cells in treatment-refractory DAGLA antibody-associated encephalitis (2025) Hegelmaier T, Wolleschak D, Pappa V, Wickel J, Geis C, Miske R, Duscha A, et al. Journal article Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatment (2025) Pelzl R, Benintende G, Gsottberger F, Scholz JK, Rübner M, Yao H, Wendland K, et al. Journal article Loss of myeloperoxidase aggravates skin and joint inflammation in the mannan-induced psoriatic arthritis mouse model (2025) Ringer M, Maccataio A, Zapf R, Gaculenko A, Adam S, Aust O, Aust O, et al. Journal article From complexity to consensus: A roadmap for neutrophil classification (2025) Ng LG, Ballesteros I, Cassatella MA, Egeblad M, Fridlender ZG, Gabrilovich D, Gao Q, et al. Journal article, Review article Predicting Disease Activity Score in Rheumatoid Arthritis Patients Treated with Biologic Disease-Modifying Antirheumatic Drugs Using Machine Learning Models (2025) Salehihafshejani F, Zarifi S, Bayat S, Habibpour M, Asemanrafat A, Kleyer A, Schett G, et al. Journal article Neutrophil Heterogeneity Identifies an Association of LAMP1 With Proliferative Lupus Nephritis (2025) Ostendorf L, Garantziotis P, Huang FY, Schett G, Lederer JA, Fava A, Rao DA, Grieshaber Bouyer R Journal article CD45 and CD148 Are Critically Involved in Neutrophil Recruitment and Function During Inflammatory Arthritis in Mice (2025) Heming JN, Margraf A, Najder K, Germena G, Richter M, Cappenberg A, Henke K, et al. Journal article Safety, tolerability and clinical effects of rovunaptabin, also known as BC007 on fatigue and quality of life in patients with Post-COVID syndrome (reCOVer): a prospective, exploratory, placebo-controlled, double-blind, randomised phase IIa clinical trial (RCT) (2025) Hohberger B, Ganslmayer M, Harrer T, Kruse F, Maas S, Borst T, Heimke-Brinck R, et al. Journal article